Results 111 to 120 of about 29,889 (292)

Narrative Review on Therapies That Influence Inflammatory Responses During Extremely Premature Perinatal Respiratory Transition

Acta Paediatrica, EarlyView.
ABSTRACT Aims and Methods Advances in neonatal care have extended borderline survival to 22–24 post‐conceptional weeks. Present review discusses approaches for prolonging short pregnancies and prevention of serious morbidities in extremely premature infants born before 28 weeks of pregnancy.
Mikko Hallman
wiley   +1 more source

Transfusion-related adverse events at the tertiary care center in North India: An institutional hemovigilance effort

Asian Journal of Transfusion Science, 2011
Aim: This study was designed to analyze the incidence and spectrum of adverse effects of blood transfusion so as to initiate measures to minimize risks and improve overall transfusion safety in the institute. Materials and Methods: During the period from
Bhattacharya Prasun, Marwaha Neelam, Dhawan Hari, Roy Pallab, Sharma R   +4 more
doaj  

Underreporting of transfusion incidents

Hematology, Transfusion and Cell Therapy
Background: Blood transfusion is an effective therapeutic practice. However, even adopting all procedures for transfusion safety, there are risks, one of which is immediate adverse reactions.
Josiane Garcia, Anna Cecília Dias Maciel Carneiro, Sheila Soares Silva, Karla Fabiana Nunes da Silva, Joilson Meneguci, Helio Moraes-Souza   +5 more
doaj   +1 more source

Successful allo‐hematopoietic stem cell transplantation using washed hematopoietic stem cells in a pediatric patient complicated by acute myeloid leukemia and severe anaphylaxis to blood product

Pediatric Investigation, EarlyView.
Jieyu Tian, Guanghua Zhu, Maoquan Qin, Chenguang Jia, Shuxuan Ma, Bin Wang, Yanhui Luo   +6 more
wiley   +1 more source

The true cost of red cell transfusion for patients with myelodysplastic syndromes: A time‐driven activity‐based costing study

British Journal of Haematology, EarlyView.
Summary Patients with myelodysplastic syndromes (MDS) often require red blood cell (RBC) transfusion. However, the true cost of RBC transfusion, beyond the acquisition cost of the unit, is poorly defined. We conducted a prospective time‐driven activity‐based costing study at a large Australian university teaching hospital.
Allison Mo, Helen Haysom, Alayna Carrandi, Sara Carrillo de Albornoz, Jessica Guglielmino, Kylie Rushford, Amanda Ellison, Dan Andrew, Angelene Jesurajah, Erin Hu, Philomina Banahene, Loo Sin Hoo, Alisa M. Higgins, Jake Shortt, Erica M. Wood, Zoe K. McQuilten   +15 more
wiley   +1 more source

Detection of Adverse Events of Transfusion in a Teaching Hospital in Ghana

, 2017
Background and objectivesMonitoring the whole chain of events from the blood donors to recipients, documenting any undesirable or untoward effects and introducing measures to prevent their recurrence if possible, are components of haemovigilance systems.
Owusu-Ofori, A. K., Owusu-Ofori, S. P., Bates, Imelda; id_orcid   +2 more
core   +1 more source

Clinical and immunological effects of adding cyclophosphamide to pomalidomide–dexamethasone in relapsed‐refractory multiple myeloma: The randomized MUKseven trial

British Journal of Haematology, EarlyView.
Summary There is an ongoing need for accessible combination therapies for patients with relapsed‐refractory multiple myeloma (RRMM), alongside a growing interest in understanding their immunological effects, particularly on T‐cell populations. Myeloma UK (MUK) MUKseven (NCT02406222) was an academic, UK multicentre randomized controlled, open‐label ...
Andrew Hall, James Croft, Katrina Walker, Kevin Boyd, Sadie Roberts, Amy Holroyd, Mamta Garg, Elsa Ferris, Gordon Cook, William E. Pierceall, Anjan Thakurta, Anita Gandhi, Charlotte Pawlyn, Sarah R. Brown, Martin Kaiser   +14 more
wiley   +1 more source

HAEMOVIGILANCE IN SLOVENIA IN YEARS 2002–2006

Zdravniški Vestnik, 2008
BACKGROUND Adverse reactions and preventive actions have accompanied transfusion medicine fromits beginning. Because of this, a haemovigilance system is imperative.
Marjeta Potočnik
doaj  

Haemostatic changes and bleeding with anti‐IL‐6 directed therapy in autoimmune diseases

British Journal of Pharmacology, EarlyView.
Abstract Anti‐IL‐6 directed therapy, especially tocilizumab (TCZ), is widely used for the treatment of autoimmune diseases such as rheumatoid arthritis, giant cell arteritis and systemic juvenile idiopathic arthritis. Next to being a master regulator of inflammation, IL‐6 also is an important regulator of haemostasis. Although generally well tolerated,
Charlotte D. C. C. van der Heijden, Loes C. Oskam, Lenny van Bon, Chantal P. Rovers   +3 more
wiley   +1 more source

Analysis of Patterns of Adverse Transfusion Reactions and Management: A Novel Initiative toward Hemovigilance in a Teaching Hospital of South India. [PDF]

J Lab Physicians, 2020
Krishnamurthy AV, Mathialagan J, Raghavan ATMV, Srinivasan S.   +3 more
europepmc   +1 more source